CAEX
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
07/08/2026
Voltar para busca
Dado oficial do USPTO
VERNALIS
Essa marca aparece no histórico oficial do USPTO.
Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Tipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
07/08/2026
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
08/04/2015
Data de registro
26/01/2016
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/08/2026
Última transação
07/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
710
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
11
Localização do titular
CAMBRIDGE, GB
Examinador
STRINGER, DANIEL
Unidade examinadora
L30
Titulares e representantes
Titulares
VERNALIS (R&D) LIMITED
Vernalis Development Limited
Vernalis Development Limited
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pastabreadscerealscrackersmeatfruitvegetablesconfectionerylipids in the nature of margarinebutter substitutelardfish oilbutterpeanut oilsoya bean oilsunflower oilsesame oilcoconut oilolive oilanimal-derived fats and oilsplant-derived oils and dairy products in the nature of cheesemilkbutteryoghurtcreamcurdsall adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders
Classe 42
Scientific and technological servicespharmaceutical product evaluationdevelopment and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluationdevelopment and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluationdevelopment and testing services; scientificmedical and clinical research and development in the nature of pharmaceutical product evaluationdevelopment and testing services; research and development in the nature of pharmaceutical product evaluationdevelopment and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluationdevelopment and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluationdevelopment and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
26/01/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/06/2022
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/06/2022
E815
TEAS SECTION 8 & 15 RECEIVED
21/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/08/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/08/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
30/06/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
16/06/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/04/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
26/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
26/01/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2015
PUBO
PUBLISHED FOR OPPOSITION
10/11/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/10/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/10/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
01/10/2015
ALIE
ASSIGNED TO LIE
01/10/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/10/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
01/10/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/10/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/09/2015
GNRT
NON-FINAL ACTION E-MAILED
25/09/2015
CNRT
NON-FINAL ACTION WRITTEN
25/09/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/07/2015
GNRT
NON-FINAL ACTION E-MAILED
23/07/2015
CNRT
NON-FINAL ACTION WRITTEN
23/07/2015
DOCK
ASSIGNED TO EXAMINER
15/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/04/2015
NWAP
NEW APPLICATION ENTERED
11/04/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VERNALIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.